CME Group Inc. (NASDAQ:CME)
CME Group Inc. (NASDAQ:CME) represented a move of 0.15 percent or $-0.98 per share and closed its previous day trading session at $181.08. 1.81 Million Shares were traded in the last trading session with an Average Volume of 1.42 Million Shares. The stock currently has a Market Capitalization of 61.43 Billion.
As the world’s leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. Around the world, CME Group brings buyers and sellers together through its CME Globex electronic trading platform. CME Group also operates one of the world’s leading central counterparty clearing providers through CME Clearing, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. CME Group’s products and services ensure that businesses around the world can effectively manage risk and achieve growth.
The stock traded between $132.33 and $183.79 over 1-Year time period showing its price to sales ratio of 15.52. CME Group Inc. (NASDAQ:CME) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $4.01 and 200-Day Simple Moving Average of $9.52. Its Price to Free Cash Flow is 338.65 and Price to Book of 2.66.
Analyst’s recommended the stock as 2.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, CME Group Inc. (NASDAQ:CME) reported its Actual EPS of $1.74/share. The analysts offering Earnings Estimates for the company were believing that CME Group Inc. could bring EPS of $1.72/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 1.2 Percent.
Oragenics Inc. (NYSE:OGEN)
In the last trading session, Oragenics Inc. (NYSE:OGEN) added its value by -0.98% closing at the price of $1.01. The stock currently has market capitalization of 29.68 Million, with average volume of 6.88 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Oragenics Inc. (NYSE:OGEN) is showing beta of 0.8. This particular value of beta suggests that Oragenics Inc. (NYSE:OGEN) has historically moved 80% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Oragenics Inc. (NYSE:OGEN) is at $-1.52.
The stock currently has RSI of 48.18. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.
Oragenics Inc. (NYSE:OGEN) topped its 52-week high price of $4.70 on 11/21/17 and 52-Week Low Price of $0.38 on 08/20/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 8.22% and monthly volatility of 31.52% respectively.